Filter
136
Text search:
mutation
Featured
Recommendations
15
New Publications
30
Language
Document type
No document type
63
Guidelines
32
Studies & Reports
22
Manuals
7
Fact sheets
4
Training Material
2
Situation Updates
2
Strategic & Response Plan
2
Brochures
1
Videos
1
Countries / Regions
India
8
Global
7
Western and Central Europe
5
Nigeria
4
Africa
4
Ethiopia
3
Germany
3
Tanzania
3
Cameroon
2
South Africa
2
Russia
2
Burkina Faso
1
Senegal
1
Congo, Democratic Republic of
1
Morocco
1
Uganda
1
Haiti
1
Philippines
1
Cambodia
1
Rwanda
1
Bangladesh
1
Mozambique
1
Benin
1
Brazil
1
Madagascar
1
Myanmar / Burma
1
South–East Asia Region
1
Latin America and the Carribbean
1
Kazakhstan
1
Vietnam
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
38
Clinical Guidelines
21
Public Health
10
Key Resources
4
Pharmacy & Technologies
3
Women & Child Health
2
Toolboxes
COVID-19
19
TB
18
HIV
14
Pharmacy
7
AMR
6
Planetary Health
5
NTDs
5
Mental Health
4
NCDs
4
Ebola & Marburg
3
Rapid Response
3
Refugee
3
Caregiver
3
2.0 Rapid Response
3
Malaria
2
Disability
1
Natural Hazards
1
Vertreter besorgniserregender Virusvarianten (variants of concern, kurz VOC) wurden weltweit aber auch in Europa, identifiziert. Molekularbiologische Details zu den Varianten sind unter SARS-CoV-2: Virologische Basisdaten und Virusvarianten abrufbar.
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
This summary covers the preventive approach to breast cancer control and includes prophylactic medications, prophylactic surgery and lifestyle modifications for breast cancer prevention. Health professional training and individual risk assessments and counseling are also discussed.
Ce rapport montre que d’importants progrès ont été accomplis en 2015 pour atteindre les cibles de la feuille de route. Ces résultats procèdent de la mise en œuvre de cinq interventions recommandées par l’OMS pour vaincre les MTN : chimiothérapie préventive ; prise en charge innovante et
...
African Journal of Laboratory Medicine | Vol 7, No 2 | a770 | 06 December 2018
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
L’antibiorésistance constitue aujourd’hui l’un des grands défis à relever à l’échelle mondiale. Il s’agit d’une menace de santé publique majeure qui impose une mobilisation déterminée et durable de l’ensemble des acteurs impliqués dans le cycle de vie des antibiotiques, afin d
...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Standard Treatment Guidelines
Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age
...
L'éducation en devenir
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
